等待开盘 05-19 09:30:00 美东时间
+0.015
+0.61%
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) today announced updated preclinical data from non-GLP diet-induced obesity (DIO) mouse studies evaluating ALN1003, the Company's investigational oral metabolic therapeutic
05-18 20:09
Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experience Joins Leadership Team SAN ANTONIO, May 4, 2026 /PRNewswire/ -- Valion Bio, Inc. (former...
05-05 04:05
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvements in select
03-02 19:37
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during T...
2025-10-09 20:07
Shares of Richardson Electronics, Ltd. (NASDAQ:RELL) rose sharply in pre-market...
2025-10-09 17:12
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
2025-09-03 18:21
Alaunos Therapeutics ( ($TCRT) ) has shared an update. On August 19, 2025, Alau...
2025-08-21 05:50
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses of $(0.71) per share from the same period last year.
2025-08-15 04:44
Alaunos Therapeutics Inc (($TCRT)) announced an update on their ongoing clinica...
2025-08-13 00:13
Alaunos Therapeutics ( ($TCRT) ) has provided an announcement. On July 16, 2025...
2025-07-23 05:20